Skip to main content
Premium Trial:

Request an Annual Quote

Guardant Health, Foundation Medicine Settle False Advertising Lawsuit

NEW YORK (GenomeWeb) – Guardant Health and Foundation Medicine said yesterday that they have settled a false advertising lawsuit that the companies had filed against each other last year.

Under the terms of the settlement, all claims and counterclaims will be dismissed with prejudice. In addition, the companies agreed to create a process to quickly resolve any future advertising-related disputes.  

The lawsuit, filed by Guardant in June of 2017 in the US District Court for the Northern District of California, related to advertising for Foundation Medicine's FoundationACT liquid biopsy genomic profiling assay. Guardant claimed that Foundation's marketing materials made false statements about its own Guardant360 test.

Foundation responded to the lawsuit in August, denying the allegations and asking for the claims to be dismissed. In addition, it filed counterclaims in September, accusing Guardant of spreading misinformation about its own test and Foundation's tissue-based assays in its advertisement.

In conjunction with the settlement, Foundation and Guardant also agreed to establish a working group to explore the development of standard formulas and definitions for the validation of genomic profiling assays.

In a statement, Guardant Health's CEO Helmy Eltoukhy and Foundation Medicine's CEO Troy Cox both said they are pleased with the resolution of the suit.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.